» Articles » PMID: 26476925

Id1 Modulates Endothelial Progenitor Cells Function Through Relieving the E2-2-mediated Repression of FGFR1 and VEGFR2 in Vitro

Overview
Publisher Springer
Specialty Biochemistry
Date 2015 Oct 19
PMID 26476925
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The migration and proliferation of EPCs are crucial for re-endothelialization in vascular repair and development. Id1 has a regulatory role in the regulation of EPCs migration and proliferation. Based on these findings, we hypothesized that Id1 plays a regulatory role in modulating the migration and proliferation of EPCs by interaction with other factors. Herein, we report that the Id1 protein and E-box protein E2-2 regulate EPCs function with completely opposite effects. Id1 plays a positive role in the regulation of EPC proliferation and migration, while endogenous E2-2 appears to be a negative regulator. Immunoprecipitation and immunofluorescence assay revealed that the Id1 protein interacts and co-localizes with the E2-2 protein in EPCs. Further, endogenous E2-2 protein was found to block EPCs function via the inhibition of FGFR1 and VEGFR2 expression. The overexpression and silencing of Id1 have no direct regulatory role on VEGFR2 and FGFR1 expression. On the other hand, Id1 relieves the E2-2-mediated repression of FGFR1 and VEGFR2 expression to modulate EPCs proliferation, migration, and tube formation in vitro. In summary, we demonstrated that Id1 and E2-2 are critical regulators of EPCs function in vitro. Id1 interacts with E2-2 and relieves the E2-2-mediated repression of FGFR1 and VEGFR2 expression to modulate EPCs functions. Id1 and E2-2 may represent novel therapeutic targets for re-endothelialization in vascular damage and repair.

Citing Articles

The Role and Research Progress of Inhibitor of Differentiation 1 in Atherosclerosis.

Qiu J, Li Y, Wang B, Sun X, Qian D, Ying Y DNA Cell Biol. 2022; 41(2):71-79.

PMID: 35049366 PMC: 8863915. DOI: 10.1089/dna.2021.0745.


Id1 and Id3 Maintain Steady-State Hematopoiesis by Promoting Sinusoidal Endothelial Cell Survival and Regeneration.

Gadomski S, Singh S, Singh S, Sarkar T, Klarmann K, Berenschot M Cell Rep. 2020; 31(4):107572.

PMID: 32348770 PMC: 8459380. DOI: 10.1016/j.celrep.2020.107572.


The Endothelium as a Driver of Liver Fibrosis and Regeneration.

Lafoz E, Ruart M, Anton A, Oncins A, Hernandez-Gea V Cells. 2020; 9(4).

PMID: 32290100 PMC: 7226820. DOI: 10.3390/cells9040929.


Liver Sinusoidal Endothelial Cell: An Update.

DeLeve L, Maretti-Mira A Semin Liver Dis. 2017; 37(4):377-387.

PMID: 29272898 PMC: 6005648. DOI: 10.1055/s-0037-1617455.

References
1.
Zampetaki A, Kirton J, Xu Q . Vascular repair by endothelial progenitor cells. Cardiovasc Res. 2008; 78(3):413-21. DOI: 10.1093/cvr/cvn081. View

2.
Watabe T . Roles of old players in the suppression of a new player: networks for the transcriptional control of angiogenesis. J Biochem. 2010; 149(2):117-9. DOI: 10.1093/jb/mvq146. View

3.
Noseda M, Chang L, McLean G, Grim J, Clurman B, Smith L . Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression. Mol Cell Biol. 2004; 24(20):8813-22. PMC: 517869. DOI: 10.1128/MCB.24.20.8813-8822.2004. View

4.
Tanaka A, Itoh F, Nishiyama K, Takezawa T, Kurihara H, Itoh S . Inhibition of endothelial cell activation by bHLH protein E2-2 and its impairment of angiogenesis. Blood. 2010; 115(20):4138-47. DOI: 10.1182/blood-2009-05-223057. View

5.
Miller-Kasprzak E, Jagodzinski P . Endothelial progenitor cells as a new agent contributing to vascular repair. Arch Immunol Ther Exp (Warsz). 2007; 55(4):247-59. DOI: 10.1007/s00005-007-0027-5. View